Insulet Corp
(STU:GOV)
€
228.1
5 (2.24%)
Market Cap: 17.41 Bil
Enterprise Value: 17.87 Bil
PE Ratio: 45.89
PB Ratio: 16.81
GF Score: 93/100 Insulet Corp at Wells Fargo Healthcare Conference Transcript
Sep 07, 2023 / 01:30PM GMT
Release Date Price:
€177.95
(-1.03%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Good morning. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with the management team from Insulet. With us, we have: Jim Hollingshead, the CEO; Wayde McMillan, the CFO; and Trang Ly, Senior Vice President and Medical Director; also in the audience, Deb Gordon, Investor Relations.
So in terms of format, it's going to be a fireside chat. If anybody has a question, please raise your hand, we'll come around with a mic. Jim, Wayde and Trang, thanks so much for being here.
James R. Hollingshead
Insulet Corporation - President, CEO & Director
Great to be here, Larry. Thank you.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
So let's start with the GLP-1s. The updates on GLP-1s are more and more positive each day, it seems. So Jim, can
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot